Search the Newsreel

Ceragon Networks Ltd (CRNT) (Q2 2026) Earnings Call Highlights: Record Bookings and Strategic ...

Ceragon Networks Ltd (CRNT) reported strong Q2 2026 results with a 14% revenue increase and record first-half bookings, driven by demand in India and a favorable competitive landscape. Despite this, the company faced challenges with declining gross margins due to product mix and supply …

Thyssenkrupp nucera AG & Co. KGaA: SOEC-Neuausrichtung führt zu Anpassung der EBIT-Prognose 2025/26; Aktualisierung der Auftragseingangs- und Umsatz-Erwartung auf Basis bisheriger Geschäftsentwicklung

Thyssenkrupp Nucera (WKN NCA000, ISIN DE000NCA0001) - Nachricht anzeigen - News

EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: SOEC-Neuausrichtung führt zu Anpassung der EBIT-Prognose 2025/26; Aktualisierung der Auftragseingangs- und Umsatz-Erwartung auf Basis bisheriger Geschäftsentwicklung - boerse.de

Ceres Power: Risk-Adjusted Significant Upside (OTCMKTS:CPWHF)

Grocery Outlet's Q2 Earnings on Deck: What Investors Should Brace For

Grocery Outlet Holding Corp. GO is scheduled to report second-quarter 2026 earnings results on Aug. 12, after the closing bell. The key question for investors is whether the extreme-value retailer of name-brand consumables and fresh products can build on its recent earnings surprise while …

Another grocery chain quietly shuts down more stores

While concern continues to rise about the cost of groceries, another major issue is quietly cropping up in your neighborhood: local grocery stores closing. During its June 2025 earnings call, Kroger announced that it would shutter 60 locations over the next 18 months, citing …

Ceragon Networks (NASDAQ:CRNT) Posts Quarterly Earnings Results

Nocera regains Nasdaq compliance with equity requirement

Nocera, Inc. (NASDAQ:NCRA) has regained compliance with Nasdaq's stockholders' equity requirement, reporting $5,435,030 against a $2.5 million minimum. This resolution, achieved through balance sheet improvements, follows an earlier regain of minimum bid price compliance, signifying the company has resolved all open listing matters. The …

NCRA Stock Jumps As Nocera Grabs Qmax AI Memory Stake

Nocera Inc. (NCRA) stock jumped over 12% after the company announced it is acquiring a 30% controlling interest in Taiwan-based Qmax Technology, a memory and storage solutions provider. This strategic, capital-light deal, executed via a Variable Interest Entity (VIE) structure with restricted shares, positions …

Earnings To Watch: Grocery Outlet Holding Corp (GO) Q2 2026 -- GF Value Sees 105% Upside

Ceragon Networks Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Ceragon Networks Ltd. reported its financial results for the second quarter and first six months of 2026. For the second quarter, sales increased to $93.91 million from $82.26 million year-over-year, but the company recorded a net loss of $2.09 million, higher than the $1.27 …

Nocera and INERGX Form 50/50 Joint Venture to Acquire and Consolidate the Mission-Critical Energy Supply Chain Serving AI Data Centers, Defense & Heavy Industry, Targeting a $250 Million Valuation...

Nocera, Inc. and INERGX Energy Optimisation Ltd have formed a 50/50 joint venture, Nocera-INERGX Energy Ventures, Inc., aimed at acquiring and consolidating the mission-critical energy supply chain for AI data centers, defense, and heavy industry. The joint venture will focus on Battery Energy Storage …

CeriBell (NASDAQ:CBLL) Receives "Buy" Rating from BTIG Research

BTIG Research has reaffirmed its "Buy" rating for CeriBell (NASDAQ:CBLL) and maintained a $28 price target, indicating a potential 45% upside from its current price of $19.30. Despite a wider-than-expected Q2 loss of $0.51 per share, the company's revenue exceeded estimates at $28.1 million. …

Nocera Clears Every Open Nasdaq Listing Matter With Stockholders' Equity of $5.4 Million - More Than Double the Required Minimum - and Turns Full Attention to Acquisitions

Nocera, Inc. announced that it has resolved all open Nasdaq listing matters, confirming compliance with stockholders' equity requirements. The company reported stockholders' equity of over $5.4 million, significantly exceeding the minimum requirement, and is now focusing entirely on its acquisition strategy and growth initiatives. …

Proposed Nocera-INERGX venture would target AI data center power

Nocera (NASDAQ: NCRA) has signed a binding term sheet with INERGX Energy Optimisation to form a 50/50 joint venture, Nocera-INERGX Energy Ventures, aiming to acquire and develop mission-critical energy infrastructure for AI data centers, defense, and heavy industry. The venture will focus on battery …

Ceragon Networks (CRNT) grows Q2 2026 revenue 14% but posts GAAP loss

Ceragon Networks reported a 14.2% increase in Q2 2026 revenue, reaching $93.9 million, primarily driven by strong demand in India. Despite this growth, the company posted a GAAP net loss of $2.1 million, though it achieved a non-GAAP net income of $1.7 million. Management …

CervoMed reports Q2 2026: $24.9M cash position, net loss $6.6M; advancing neflamapimod toward Phase 3

CervoMed reported its second-quarter 2026 results, highlighting a cash position of approximately $24.9 million and a net loss of $6.6 million. The company completed two equity financings in June, raising $20.5 million, extending its cash runway through Q3 2027. CervoMed is strategically focusing on …

Canaccord raises Ceribell stock price target on strong Q2 results

Canaccord increased its price target for Ceribell (NASDAQ:CBLL) to $26 from $25, maintaining a Buy rating, following strong Q2 fiscal 2026 results. The company reported $28.1 million in revenue, a 33% year-over-year increase, and raised its full-year revenue guidance to $114 million-$117 million. Despite …

$Nocera (NCRA.US)$ hit the first profit target for shorting, second profit target. and now trying for third profit target.

The article by Stocktraderchia states that Nocera (NCRA.US) has reached its first and second profit targets for short selling and is now aiming for the third profit target. This comment was posted on moomoo community. The author, Stocktraderchia, claims over 15 years of daytrading …

Ausbil Investment Management Ltd Buys 3,569 Shares of RenaissanceRe Holdings Ltd. $RNR

Ceragon Networks Ltd (CRNT) Earnings Forecast: Future EPS & Revenue Growth Estimates

Nocera Inc (NCRA) Earnings Forecast: Future EPS & Revenue Growth Estimates

CeriBell, Inc. (CBLL) Reports Q2 Loss, Tops Revenue Estimates

CeriBell, Inc. (CBLL) reported a Q2 loss of $0.51 per share, missing the Zacks Consensus Estimate of a $0.45 loss, but exceeded revenue estimates with $28.1 million. Despite underperforming the S&P 500 this year, the company's revenue has topped consensus estimates four times in …

CeriBell Lifts 2026 Revenue Forecast on AI EEG Growth, Reports Wider Quarterly Loss

Ceribell has raised its 2026 revenue forecast to $114-$117 million after a 33% increase in Q2 sales, driven by new hospital accounts and higher utilization. Despite strong growth, the GAAP net loss widened by 41% to $19.3 million due to operating expenses rising faster …

Ceribell Receives FDA Clearance for Advanced Epileptiform Abnormality Detection and Artifact Reduction for Its Cloud-Based Portal, Delivering Greater Precision for Critical-Care EEG Review

Ceribell, Inc. announced FDA 510(k) clearance for two new AI algorithm enhancements for its cloud-based Neurology Portal: Epileptiform Abnormality Detection and Artifact Reduction. These enhancements aim to improve the precision and efficiency of critical-care EEG review by filtering complex background interference and streamlining the …

CeriBell Inc (CBLL) (Q2 2026) Earnings Call Highlights: Revenue Accelerates 33% on Record ...

CeriBell Inc (CBLL) reported a significant revenue increase of 33% year-over-year to $28.1 million in Q2 2026, driven by strong product and subscription growth. Despite widening net losses due to increased operating expenses and IP litigation costs, the company achieved a record gross margin …

Cerence Inc. (NASDAQ:CRNC) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year

Cerence Inc. recently released its third-quarter results, showing revenues of US$70m and EPS of US$0.03, which were largely in line with estimates. Analysts have since updated their forecasts, maintaining revenue estimates at US$290.2m for 2027 but significantly increasing EPS expectations to US$0.45, suggesting increased …

CeriBell Q2 revenue rises 33%, raises FY26 guidance to $114M-$117M

Slate Grocery REIT 2026 Q2 - Results - Earnings Call Presentation (TSX:SGR.UN:CA) 2026-08-10

Bioceres Crop Solutions (BIOX) CEO reports 130,000-share bona fide gift via trust

Bioceres Crop Solutions CEO Federico Trucco reported a bona fide gift of 130,000 Ordinary Shares transferred via the Testamentario MQT Trust for the benefit of his child on May 20, 2026. Following this transaction, he disclaims beneficial ownership of these shares except for any …

Here's What Key Metrics Tell Us About CeriBell, Inc. (CBLL) Q2 Earnings

CeriBell (NASDAQ:CBLL) Releases Earnings Results

Ceribell forecasts FY 2026 revenue of $114 million-$117 million

Ceribell has issued a revenue guidance for FY 2026, projecting $114 million-$117 million. The company reported a 33% year-over-year revenue increase in Q2 2026 and a year-to-date gross margin of 90% as of June 30, 2026. Ceribell estimates a U.S. market opportunity of $3.5 …

Earnings call transcript: Ceribell tops revenue growth in Q2 2026, shares rise

Ceribell reported strong Q2 2026 results, with revenue growing 33% year-over-year to $28.1 million, surpassing expectations despite an EPS miss. The medical-device company's shares rose as investors focused on its continued expansion in seizure detection, record gross margins of 92%, and advancement of new …

Canaccord cuts CervoMed stock price target on funding uncertainty

Canaccord Genuity lowered its price target on CervoMed Inc. to $18 from $27, citing uncertainty regarding funding for the company's lead drug candidate, neflamapimod, despite maintaining a Buy rating. The stock has seen a significant decline, but the firm believes it remains undervalued due …